Jean-Pol Detiffe has founded and will serve as CEO of OncoDNA, a new subsidiary of the Institute of Pathology and Genetics in Gosselies, Belgium (see story, this issue).
Detiffe founded and was previously CEO of DNAVision. He was also project and business development manager of Bio.be, also part of the Institute of Pathology and Genetics, and has served on the boards of DNALytics, Immune Health, Biowin, and DNAVision Agrifood.
Additionally, Pierre Lefesvre will serve as OncoDNA's medical director.
He is a medical pathologist at IPG.